Atazanavir

In the US, Atazanavir (atazanavir systemic) is a member of the drug class protease inhibitors and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AE08

CAS registry number (Chemical Abstracts Service)

0198904-31-3

Chemical Formula

C38-H52-N6-O7

Molecular Weight

704

Therapeutic Categories

Antiviral agent

Treatment of HIV infection

HIV protease inhibitor

Chemical Names

(3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydoxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester

(S)-{1-[N'-[(2S,3S)-2-Hydroxy-3-((S-methoxycarbonylamino-3,3-dimethylbutyrylamino)-4- phenylbutyl]-N'-(4-pyridin-2-ylbenzyl)hydrazinocarbonyl]-2,2-dimetehylethylpropyl} carbaminsäuremethylester (IUPAC)

Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate (WHO, BAN)

Foreign Names

  • Atazanavirum (Latin)
  • Atazanavir (German)
  • Atazanavir (French)
  • Atazanavir (Spanish)

Generic Names

  • Atazanavir (OS: BAN)
  • BMS 232632 (IS: Bristol-Myers)
  • CGP 73547 (IS: Novartis)
  • Latazanavir (IS)
  • UNII-QZU4H47A3S (IS)
  • Zrivida (IS)
  • Atazanavir Sulfate (OS: USAN, BANM, JAN)
  • BMS-232632-05 (IS: Bristol-Myers)
  • UNII-4MT4VIE29P (IS)

Brand Names

  • Reyataz
    Bristol-Myers Squibb, Argentina; Bristol-Myers Squibb, Belgium; Bristol-Myers Squibb, Chile; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Georgia; Bristol-Myers Squibb, Greece
  • Atazanavir
    Emcure, United States
  • Reyataz
    Abeefe Bristol-Myers Squibb, Peru; Bristol Myers Squibb, Spain; Bristol-Myers Squibb, Austria; Bristol-Myers Squibb, Australia; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Switzerland; Bristol-Myers Squibb, China; Bristol-Myers Squibb, Czech Republic; Bristol-Myers Squibb, Germany; Bristol-Myers Squibb, Denmark; Bristol-Myers Squibb, Finland; Bristol-Myers Squibb, France; Bristol-Myers Squibb, United Kingdom; Bristol-Myers Squibb, Hong Kong; Bristol-Myers Squibb, Hungary; Bristol-Myers Squibb, Indonesia; Bristol-Myers Squibb, Ireland; Bristol-Myers Squibb, Israel; Bristol-Myers Squibb, Italy; Bristol-Myers Squibb, Japan; Bristol-Myers Squibb, South Korea; Bristol-Myers Squibb, Lithuania; Bristol-Myers Squibb, Malaysia; Bristol-Myers Squibb, Netherlands; Bristol-Myers Squibb, Norway; Bristol-Myers Squibb, New Zealand; Bristol-Myers Squibb, Poland; Bristol-Myers Squibb, Portugal; Bristol-Myers Squibb, Romania; Bristol-Myers Squibb, Russian Federation; Bristol-Myers Squibb, Sweden; Bristol-Myers Squibb, Singapore; Bristol-Myers Squibb, Slovenia; Bristol-Myers Squibb, Slovakia; Bristol-Myers Squibb, Thailand; Bristol-Myers Squibb, Tunisia; Bristol-Myers Squibb, Taiwan; Bristol-Myers Squibb, United States; Bristol-Myers Squibb, South Africa; Bristol-Myers Squibb Phar, Luxembourg
  • REYATAZ
    Bristol Myers Squibb, Latvia

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)